These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 20382755

  • 1. Expression and characterization of dog cytochrome P450 2A13 and 2A25 in baculovirus-infected insect cells.
    Zhou D, Linnenbach AJ, Liu R, Luzietti RA, Harris JJ, Booth-Genthe CL, Grimm SW.
    Drug Metab Dispos; 2010 Jul; 38(7):1015-8. PubMed ID: 20382755
    [Abstract] [Full Text] [Related]

  • 2. Substrate specificity and kinetic properties of seven heterologously expressed dog cytochromes p450.
    Shou M, Norcross R, Sandig G, Lu P, Li Y, Lin Y, Mei Q, Rodrigues AD, Rushmore TH.
    Drug Metab Dispos; 2003 Sep; 31(9):1161-9. PubMed ID: 12920172
    [Abstract] [Full Text] [Related]

  • 3. Substrate specificity for rat cytochrome P450 (CYP) isoforms: screening with cDNA-expressed systems of the rat.
    Kobayashi K, Urashima K, Shimada N, Chiba K.
    Biochem Pharmacol; 2002 Mar 01; 63(5):889-96. PubMed ID: 11911841
    [Abstract] [Full Text] [Related]

  • 4. Newly Identified Tree Shrew Cytochrome P450 2A13 is Expressed in Liver and Lung and Encodes a Functional Drug-Metabolizing Enzyme Similar to Dog Cytochrome P450 2A13 and Pig Cytochrome P450 2A19.
    Ushirozako G, Noda Y, Murayama N, Kawaguchi H, Tsukiyama-Kohara K, Yamazaki H, Uno Y.
    Drug Metab Dispos; 2023 May 01; 51(5):610-617. PubMed ID: 36669854
    [Abstract] [Full Text] [Related]

  • 5. Expression and characterization of canine cytochrome P450 2D15.
    Roussel F, Duignan DB, Lawton MP, Obach RS, Strick CA, Tweedie DJ.
    Arch Biochem Biophys; 1998 Sep 01; 357(1):27-36. PubMed ID: 9721180
    [Abstract] [Full Text] [Related]

  • 6. The inhibitory effect of tannic acid on cytochrome P450 enzymes and NADPH-CYP reductase in rat and human liver microsomes.
    Yao HT, Chang YW, Lan SJ, Yeh TK.
    Food Chem Toxicol; 2008 Feb 01; 46(2):645-53. PubMed ID: 17950511
    [Abstract] [Full Text] [Related]

  • 7. Functional high level expression of cytochrome P450 CYP2D6 using baculoviral expression systems.
    Paine MJ, Gilham D, Roberts GC, Wolf CR.
    Arch Biochem Biophys; 1996 Apr 01; 328(1):143-50. PubMed ID: 8638923
    [Abstract] [Full Text] [Related]

  • 8. Specificity of substrate and inhibitor probes for human cytochromes P450 1A1 and 1A2.
    Tassaneeyakul W, Birkett DJ, Veronese ME, McManus ME, Tukey RH, Quattrochi LC, Gelboin HV, Miners JO.
    J Pharmacol Exp Ther; 1993 Apr 01; 265(1):401-7. PubMed ID: 8474022
    [Abstract] [Full Text] [Related]

  • 9. Expression and coupling of human cytochrome P450 2E1 and NADPH-cytochrome P450 oxidoreductase in dual expression and co-infection systems with baculovirus in insect cells.
    Wang MH, Patten CJ, Yang GY, Paranawithana SR, Tan Y, Yang CS.
    Arch Biochem Biophys; 1996 Oct 15; 334(2):380-8. PubMed ID: 8900414
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of approach to predict the contribution of multiple cytochrome P450s in drug metabolism using relative activity factor: effects of the differences in expression levels of NADPH-cytochrome P450 reductase and cytochrome b(5) in the expression system and the differences in the marker activities.
    Nakajima M, Tane K, Nakamura S, Shimada N, Yamazaki H, Yokoi T.
    J Pharm Sci; 2002 Apr 15; 91(4):952-63. PubMed ID: 11948533
    [Abstract] [Full Text] [Related]

  • 11. Baculovirus expression of human P450 2E1 and cytochrome b5: spectral and catalytic properties and effect of b5 on the stoichiometry of P450 2E1-catalyzed reactions.
    Patten CJ, Koch P.
    Arch Biochem Biophys; 1995 Mar 10; 317(2):504-13. PubMed ID: 7893169
    [Abstract] [Full Text] [Related]

  • 12. Cytochrome P450 inhibition using recombinant proteins and mass spectrometry/multiple reaction monitoring technology in a cassette incubation.
    Weaver R, Graham KS, Beattie IG, Riley RJ.
    Drug Metab Dispos; 2003 Jul 10; 31(7):955-66. PubMed ID: 12814974
    [Abstract] [Full Text] [Related]

  • 13. CYP2A13 metabolizes the substrates of human CYP1A2, phenacetin, and theophylline.
    Fukami T, Nakajima M, Sakai H, Katoh M, Yokoi T.
    Drug Metab Dispos; 2007 Mar 10; 35(3):335-9. PubMed ID: 17178771
    [Abstract] [Full Text] [Related]

  • 14. Reconstitution premixes for assays using purified recombinant human cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5.
    Shaw PM, Hosea NA, Thompson DV, Lenius JM, Guengerich FP.
    Arch Biochem Biophys; 1997 Dec 01; 348(1):107-15. PubMed ID: 9390180
    [Abstract] [Full Text] [Related]

  • 15. cDNA-directed expression of human cytochrome P450 CYP1A1 using baculovirus. Purification, dependency on NADPH-P450 oxidoreductase, and reconstitution of catalytic properties without purification.
    Buters JT, Shou M, Hardwick JP, Korzekwa KR, Gonzalez FJ.
    Drug Metab Dispos; 1995 Jul 01; 23(7):696-701. PubMed ID: 7587956
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of Escherichia coli membrane preparations of canine CYP1A1, 2B11, 2C21, 2C41, 2D15, 3A12, and 3A26 with coexpressed canine cytochrome P450 reductase.
    Locuson CW, Ethell BT, Voice M, Lee D, Feenstra KL.
    Drug Metab Dispos; 2009 Mar 01; 37(3):457-61. PubMed ID: 19074522
    [Abstract] [Full Text] [Related]

  • 17. Metabolism of human cytochrome P450 marker substrates in mouse: a strain and gender comparison.
    Löfgren S, Hagbjörk AL, Ekman S, Fransson-Steen R, Terelius Y.
    Xenobiotica; 2004 Sep 01; 34(9):811-34. PubMed ID: 15742976
    [Abstract] [Full Text] [Related]

  • 18. Optimization of heme precursors for the expression of human cytochrome P450 2A13 and its co-expression with oxidoreductase in baculovirus/sf9 system.
    Lu HY, Qiu LL, Yang XJ, Zhang XM, Zhang Z, Wang SL.
    J Biochem; 2013 Jun 01; 153(6):555-63. PubMed ID: 23463547
    [Abstract] [Full Text] [Related]

  • 19. Identification of human cytochrome P450 isoforms involved in the 3-hydroxylation of quinine by human live microsomes and nine recombinant human cytochromes P450.
    Zhao XJ, Yokoyama H, Chiba K, Wanwimolruk S, Ishizaki T.
    J Pharmacol Exp Ther; 1996 Dec 01; 279(3):1327-34. PubMed ID: 8968357
    [Abstract] [Full Text] [Related]

  • 20. Characterization of substrate specificity of dog CYP1A2 using CYP1A2-deficient and wild-type dog liver microsomes.
    Mise M, Hashizume T, Komuro S.
    Drug Metab Dispos; 2008 Sep 01; 36(9):1903-8. PubMed ID: 18573860
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.